Rebecca Yee is the Chief of Microbiology at the George Washington University Hospital and Assistant Professor in the Department of Pathology at George Washington University in Washington D.C, USA. Before joining GW, she completed a medical and public health microbiology fellowship at Children’s Hospital Los Angeles and Los Angeles County, University of Southern California (LACUSC) Hospital. She holds a BA from the University of Pennsylvania and a Ph.D. from Johns Hopkins University. She serves on working groups and committees for the Clinical Laboratory Standards Institute (CLSI), American Society for Microbiology (ASM), Association for Molecular Pathology (AMP), and the American Society for Clinical Pathology (ASCP). Her research interests are in the development of novel, more rapid diagnostics for infectious disease diagnoses and antimicrobial resistance detection. She is interested in emerging antimicrobial resistance mechanisms and exploring the role of novel laboratory diagnostic tools in facilitating antimicrobial stewardship programs to reduce costs, optimize therapeutic outcomes, and reduce antimicrobial resistance.
Rebecca Yee is the Chief of Microbiology at the George Washington University Hospital and Assistant Professor in the Department of Pathology at George Washington University in Washington D.C, USA. Before joining GW, she completed a medical and public health microbiology fellowship at Children’s Hospital Los Angeles and Los Angeles County, University of Southern California (LACUSC) Hospital. She holds a BA from the University of Pennsylvania and a Ph.D. from Johns Hopkins University. She serves on working groups and committees for the Clinical Laboratory Standards Institute (CLSI), American Society for Microbiology (ASM), Association for Molecular Pathology (AMP), and the American Society for Clinical Pathology (ASCP). Her research interests are in the development of novel, more rapid diagnostics for infectious disease diagnoses and antimicrobial resistance detection. She is interested in emerging antimicrobial resistance mechanisms and exploring the role of novel laboratory diagnostic tools in facilitating antimicrobial stewardship programs to reduce costs, optimize therapeutic outcomes, and reduce antimicrobial resistance.